Immuron (IMRN) Operating Income (2016 - 2024)

Immuron's (IMRN) quarterly Operating Income came in at -$1.7 million in Q4 2024, up 17.81% year-on-year from -$1.4 million in Q1 2024, and up 17.81% quarter-over-quarter from -$2.0 million in Q4 2023.

Immuron (IMRN) Operating Income (2016 - 2024) Analysis & Trends

Immuron's Operating Income history runs 9 years deep, the most recent figure standing at -$1.7 million for Q4 2024.

  • On a quarterly basis, Operating Income rose 17.81% year-over-year to -$1.7 million in Q4 2024; TTM through Dec 2024 was -$6.9 million, a 31.61% decrease from a year earlier, with the FY2025 full-year figure at -$3.5 million, up 8.95% from the prior year.
  • Operating Income improved to -$1.7 million in Q4 2024 per IMRN's latest filing, from -$2.0 million in the prior quarter.
  • Across five years, Operating Income topped out at -$13326.4 in Q4 2021 and bottomed at -$2.0 million in Q4 2023.
  • The 5-year median for Operating Income is -$1.5 million (2023), against an average of -$1.2 million.
  • Across the five-year window, Operating Income jumped 76.77% in 2021 and plunged 14429.23% in 2022, its largest moves.
  • Year by year, Operating Income stood at -$57371.6 in 2020, then soared by 76.77% to -$13326.4 in 2021, then plunged by 14429.23% to -$1.9 million in 2022, then slipped by 4.33% to -$2.0 million in 2023, then advanced by 17.81% to -$1.7 million in 2024.
  • Per Business Quant, the three latest IMRN Operating Income figures stand at -$1.7 million (Q4 2024), -$2.0 million (Q4 2023), and -$1.2 million (Q2 2023).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -27.75 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -15.76 Mn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 249.90 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 1.14 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 642.90 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - -32.68 Mn
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 394.00 Mn
9 Revolution Medicines 37.37 Bn 37.37 Bn - -445.22 Mn
10 Immuron 255.19 Mn 243.53 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 -1.66 Mn
Dec 31, 2023 -2.02 Mn
Jun 30, 2023 -1.24 Mn
Dec 31, 2022 -1.94 Mn
Dec 31, 2021 -13,326.36
Dec 31, 2020 -57,371.61
Dec 31, 2019 -15,191.40
Dec 31, 2018 -1.58 Mn
Dec 31, 2017 3.84 Mn
Dec 31, 2016 2.55 Mn
Jun 30, 2016 4.33 Mn